News
- Author:
- Mary Ann Moon
Publish date: November 27, 2013
Major finding: Progression-free survival was significantly longer with afatinib (11.1 months) than with combination chemotherapy (6.9 months), tre...
News
- Author:
- Mary Ann Moon
Publish date: November 26, 2013
Major finding: Of 28 patients receiving thalidomide, 13 (46.4%) achieved clinical remission at week 8, compared with 3 of 26 patients receiving pl...
News
- Author:
- Mary Ann Moon
Publish date: November 25, 2013
Major finding: Only 3 of the 34 characteristics of chest pain differed significantly enough between men and women to possibly enhance diagnosis of...
News
- Author:
- Mary Ann Moon
Publish date: November 25, 2013
Major Finding: Studies examining barriers to HPV vaccination among health care professionals and parents both cited the lack of a physician’...
News
- Author:
- Mary Ann Moon
Publish date: November 25, 2013
Major Finding: Studies examining barriers to HPV vaccination among health care professionals and parents both cited the lack of a physician’...
News
- Author:
- Mary Ann Moon
Publish date: November 20, 2013
Major finding: Twenty-one cases of infection were confirmed and 23 clinically compatible cases were reported in southern Xinjiang; polio virus was...
News
- Author:
- Mary Ann Moon
Publish date: November 19, 2013
Major finding: Only 25% of the women in one study and 21% in the other who underwent breast MRI met the high-risk criteria recommended for the pro...
News
- Author:
- Mary Ann Moon
Publish date: November 18, 2013
Major Finding: Patients who took varespladib had a significantly higher rate of MI (3.4%) than those who took placebo (2.2%), with a hazard ratio ...
News
- Author:
- Mary Ann Moon
Publish date: November 18, 2013
Major Finding: The primary end point – the degree of LV reverse remodeling, as measured by the left ventricular end-systolic volume index on...
News
- Author:
- Mary Ann Moon
Publish date: November 13, 2013
Major Finding: At median follow-ups of 86 and 73 months, respectively, the HIV-negative group had a 95% rate of freedom from disease progression a...
News
- Author:
- Mary Ann Moon
Publish date: November 11, 2013
Major Finding: Bardoxolone methyl improved eGFR and may have delayed progression to ESRD, but that result was inconclusive because the trial was t...
News
- Author:
- Mary Ann Moon
Publish date: November 11, 2013
News
- Author:
- Mary Ann Moon
Publish date: November 6, 2013
Major finding: The proportional hazard ratio of undergoing antireflux surgery was markedly decreased for patients aged 7 months to 4 years (0.63) ...
News
- Author:
- Mary Ann Moon
Publish date: November 5, 2013
Major finding: In patients with MET-positive tumors, overall survival was nearly three times longer with erlotinib plus onartuzumab (12.6 months) ...
News
- Author:
- Mary Ann Moon
Publish date: November 5, 2013
Major Finding: The absolute risk of death, MI, or ischemic stroke was 5.8% higher in men taking any formulation of testosterone therapy than in th...
